Eli Lilly Began Construction on Houston Campus
The $6.5 billion facility will produce the oral diabetes medication orforglipron.
Updated on Sept. 21, 2026 in Diabetes
Live Poll
Do you support providing large tax incentives to attract major corporations to your area?
Eli Lilly has officially launched construction on a 236-acre campus in Houston at Generation Park. The site is slated to manufacture orforglipron, an oral GLP-1 drug that received FDA approval in April 2026.
Why it matters
This massive investment aims to scale up production of critical GLP-1 diabetes treatments to meet growing demand. The project is bolstered by significant state financial support designed to boost the local economy.
The campus spans 236 acres and will feature six buildings totaling 808,359 square feet. Construction is supported by $146 million in state tax incentives and a $5.5 million grant from the Texas Enterprise Fund.
The players
Eli Lilly
This global pharmaceutical company is a major manufacturer of diabetes and weight-loss medications.
The details
The development is expected to generate 4,000 construction jobs and 615 permanent roles upon completion. The facility is being built in Generation Park near Beltway 8 to support the supply chain for orforglipron.
Timeline
The FDA granted approval for orforglipron in April 2026.
A ground-breaking ceremony for the campus was held on September 21, 2026.
Construction activities are scheduled to conclude in November 2027.
Health Landscape
The project follows the pattern set by the Jobs, Energy, Technology and Innovation program in incentivizing large-scale industrial manufacturing growth. This facility expansion mirrors a broader shift as pharmaceutical firms localize supply chains for GLP-1 medications.
This campus expansion is intended to increase the domestic availability and manufacturing capacity of oral diabetes treatments. While the project adds thousands of jobs to the local economy, patients should expect continued reliance on existing supply chains until the facility is operational.
The takeaway
Large-scale manufacturing investments represent a long-term commitment by pharmaceutical companies to stabilize the supply of high-demand medications. Local residents will see immediate job growth throughout the construction phase ending in 2027.
What happens next
The construction project is expected to reach its completion phase in November 2027.
Further reading
For more on developments in the field, explore the Diabetes section.
Live Poll
Do you support providing large tax incentives to attract major corporations to your area?
